What’s “The Netflix of Medicine” Being Teased by Technology & Opportunity?

by Travis Johnson, Stock Gumshoe | May 14, 2018 3:05 pm

Sniffing out a teaser stock from Jason Stutman

We’ll start the week out with a teaser pitch I’ve been seeing from Jason Stutman[1] for his Technology & Opportunity newsletter. As with so many stocks that are hinted at, this one plucks at our greed-strings via comparison with a massive success story — this time it’s Netflix, as Stutman refers to his “secret” pick as the “Netflix of Medicine.”

So… hoodat? Let’s start you off with a little taste of the ad:

“The Netflix of Medicine

“One unknown tech company is primed to dominate the $379 billion digital health market.

“Here’s why it could hand you nine times your money by mid-2018….

“Physical doctor’s visits are quickly becoming a thing of the past.

“No driving, no sitting in waiting rooms, no dealing with snarky receptionists…

“No wasted time, no going out when you’re sick, no sitting next to other germ-infested patients…

“Just simple, effective, and convenient care.

“It’s a revolution known as digital health. And as you might imagine, it’s growing at an astonishing rate.”

That Netflix comparison comes from what he calls “physical disruption” — turning a physical experience into a digital one. For Netflix it was doing away with the video store (and later the DVD-by-mail experience) and providing digital video streaming… for this teased stock it’s what’s often called “telemedicine.” More from the ad…

“Until recently, doctor’s offices were a necessity.

“If you got sick, you’d have to go into the office.

“It was the same thing if you’d needed a prescription refill and an ordinary checkup.

“But that’s all changing.

“Thanks to ‘digital doctors,’ you can get instant health care at the touch of a button….

“Just like an in-person visit, the doctor takes your history and symptoms, performs an exam, and will recommend treatment.

“And it’s not just for if you have the flu or a bacterial infection, either…

“Digital doctors can provide treatment for 90% of the most common health conditions.”

OK, so yes, doctor’s visits via video chat — that’s a trend that’s been gradually developing for a long time, and which has seen a few waves of minor investor mania in the past 15 years or so. Which company is being teased here?

We don’t get a lot of clues, but there is this…

“… one small company has a grip on 75% of this entire industry.”

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


And this…

“The tiny tech company that I’ll tell you about today has saved patients an average of $500 per visit — a total of $493 million over a full year.

“And the company isn’t just saving its patients stacks of cash, it’s also saving them time, as well…..

“The Netflix of medicine isn’t just doing well for its customers, either. It’s also doing well for itself and its investors.

“This tiny company serves more than 20 million members with just 3,000 doctors, which keeps its operating costs incredibly low.

“And it just signed on 50,000 more doctors, opening the floodgates for tens of millions of new members.

“On top of that, its assets are worth more than twice its liabilities, even as a startup.”

And we’re told that this is the ONLY company in “this space” that has become profitable so far. Which certainly helps.

How big is this market? We get some more numbers from Stutman in the ad:

“Even though it’s relatively new, the industry has already shot from $240 million in 2013 to $2 billion today.

“But the truth is that this is just the beginning…

“Two years from now, the digital health market is predicted to be worth $86 billion:

“And by 2024, it’s set to hit $379 billion….”

We can probably all imagine what kind of risks this sort of company will face — regulation, liability, dealing with insurance companies, etc., so we won’t get too hung up on guessing what the risks are that this industry doesn’t hit $379 billion in the next six years, we’ll stick with the actual company and look at its real financials.

But to do that, of course, we first need a name — and the Thinkolator obliges, as it so often does. All those clues point straight at Teladoc (TDOC)[2], which is, yes, pretty much the only large “pure play” telemedicine company, and one of the few, out of a wave of digital medicine startups, to have actually gone public.

So they seem to have a bit of a “first mover advantage,” if you believe their own assessments of the market — they do say they have 75% market share, over non-public competitors like Dr. Phil’s Doctor on Demand and American Well[3]. And about 2/3 of states are apparently on board, requiring that virtual doctor’s visits be covered by insurers the same as in-person visits.

Which probably brings up the most important point: Patients are not likely to be the customers as long as our medical system is primarily controlled by private and governmental insurance programs… patients may decide what service they like, but it will be insurers who decide which services to cover, or which services to point their patients toward, and it will be insurers who pay most of the bill, most of the time. At least, outside of the “early adopter” customer group that can afford to pay their own $200 visit fee (or whatever it might be) for convenience.

I don’t know how this particular segment of the doctor-delivery industry will evolve, or whether there will be one or a few dominant providers like there are now, or if something completely different will happen… but Teladoc is pretty big right now, with a $3 billion market cap, and they are the only ones who can really capitalize on investor attention… at least, until American Well or another provider decides to go public.

That’s probably the biggest risk, that although Teladoc is likely the largest and the most visible company in telemedicine right now (at least for investors), there are easily dozens of other fairly substantial companies vying for some space in this segment, from American Well to MDLive to First Opinion to PlushCare to the Uber[4]-inspired Pager (in-person “doctor delivery”), to technology vendors like Spruce or SnapMD who are trying to sell telemedicine services to doctors instead of to patients and insurers. It’s early days, to be sure… though, of course, when Netflix was still primarily a DVD-by-mail company there were also other streaming technologies and services trying to take the lead in that space.

So I have some sympathy for the guess that Teladoc will continue to lead, if only because there’s a huge first mover advantage in getting a large base of physicians, patients and insurers comfortable with your service.

Will that make them profitable? Maybe. They’ve just about doubled their number of members to 23 million since going public in mid-2015, and expect almost two billion visits and 8% utilization of their service in 2018, with strong revenue growth (50% growth expected in 2018) and a pretty large number of clients (300+ Fortune 1000 companies, 35+ health plans, 250% hospitals and health systems, all according to their March Investor Presentation[5]).

And while they might not technically be profitable (their guidance is that they still think they’ll lose at least $1.36 per share in 2018), on a non-GAAP measure their Adjusted EBITDA will be positive. That, along with a strong first quarter announced a couple weeks ago, was enough to generate a nice reception for their latest capital raise, which was a convertible bond offering, and the stock has been surging this year.

Like many startups, Teladoc has to basically balance itself between maximizing profit and investing in growth, and they’re choosing to invest pretty heavily in growth, through both acquisitions and pretty heavy marketing spending… presumably because they want to protect and grow their market share as this still fairly small segment matures. So they’re not terribly likely to become super-profitable, but their margins have been gradually improving — when they first came public they were spending $1.75 for every dollar of revenue they brought, and last year that had improved to $1.45, so that’s good, and the top-line revenue growth (more than 50%) and the efficiency of their model should let them turn profitable soon if that becomes a priority.

The valuation on a price/sales basis is pretty high, roughly 10X sales (when Netflix was growing revenues at 25% five years ago, for example it was down at about 5X sales, though the comparison is not terribly apt in any other way).

And, well, that’s about all I can tell you after reviewing a few investor presentations and looking at their numbers. I’m pretty sympathetic with the notion that a lot of routine medical care will move to the virtual world, but even if that’s true I think much of the investment premise at this point will be based on your judgement about “are they far enough ahead of their competitors to continue to dominate,” and I can’t answer that without looking into the client base of those other major competitors and interviewing customers or trying out the different products from Doctors on Demand or American Well and trying to really determine whether they have any kind of sustainable advantage.

I can tell you that on an earnings basis, analysts still expect them to be losing money next year, with the average analyst predicting 96 cents as the “loss per share” number for 2019, but that also assumes a pretty rapid deceleration of revenue growth (from 50% this year to about 25% growth next year). I don’t know whether that’s fair or not, but it does leave room for the possibility that the analysts are being too conservative.

So… sound like your kind of story? Expect great things from the “Netflix of Medicine,” or do you think the valuation is too rich, or the competition too stiff? Let us know with a comment below. Thanks for reading!

P.S. There’s also a “retire early from the death of Monsanto” pitch for a second “special report” in this ad — that’s one we covered a while ago, the stock’s down about 20% from when we covered the teaser of that pick back in December[6].

Endnotes:
  1. Jason Stutman: https://www.stockgumshoe.com/tag/jason-stutman/
  2. Teladoc (TDOC): https://www.stockgumshoe.com/tag/tdoc/
  3. American Well: https://www.stockgumshoe.com/tag/american-well/
  4. Uber: https://www.stockgumshoe.com/tag/uber/
  5. March Investor Presentation: http://s21.q4cdn.com/672268105/files/doc_presentations/2018/03/Teladoc-March-Investor-Presentation.pdf
  6. we covered the teaser of that pick back in December: https://www.stockgumshoe.com/reviews/technology-opportunity/a-tiny-biotech-controls-agricultural-technology-that-could-end-food-shortages-forever/

Source URL: https://www.stockgumshoe.com/reviews/technology-opportunity/whats-the-netflix-of-medicine-being-teased-by-technology-opportunity/


37 responses to “What’s “The Netflix of Medicine” Being Teased by Technology & Opportunity?”

  1. does anyone really want to talk to a phone and be diagnosed by a robot which may write your prescription for the pharmacy? where is bedside manner when you are sick and need to feel that someone will cure you?

  2. kentusm says:

    Hey, I married nurse “rachet”. I’ll take the robot.

  3. Dr G Smith says:

    While I think its a great long term future option, I don’t see a shift in the near term, partially due to the liability and other legal issues due to increased rates of misdiagnosis and other practical issues. Significant restructuring of how the US health care system functions (e.g. liability) is required.

    Where I do see near term value in the US is in how groups like UC Davis are using it: put in the telemedicine units at rural hospitals and clinics to allow access to specialists. The key here is that there is a licensed practitioner on both sides.

    Value in less developed countries is more immediate but there is less stockholder benefit there.

  4. bagels88 says:

    I actually used Teledoc a couple of days ago. My insurance company, Emblem health, sent me a membership card several weeks ago. As you all may or may not know, Emblem is pretty big. Anyway, it was a very good experience. I will probably take a position on a dip, as I think this company will ultimately be successful.

  5. elk82070 says:

    I like the concept long term. What I don’t like is the near 100% bump since November and the near 20% bump in the last 10 days. I also don’t care for its near 80% underperformance rating and most rate as a sell. I prefer to buy the dip and not chase the ride. But I’ve been wrong so many times before. Should it dip below $40 I could find it very appealing. But for now it is definitely worth watching.

  6. yukonjack says:

    Digital doctors…just another way to push prescriptions. Other than give you drugs, what can robots do…order you up a pot of chicken soup and have it delivered hot by Amazon? I would never use it because I am trying my darnedest to never have to take any drugs, except very rarely in a critical situation. Thus far, I am 68 and not on any prescriptions. Sorry for those who are in pain and need medicine. I just feel that Big Pharma’s code of operation is better health through the use of drugs, which is a supreme failure, except for the enormous over-charges paid by insurance companies at our expense. I can see people flocking to this service because of the convenience. But, I don’t think it will be a profitable business. Look at UBER…highly practical and convenient, yet they lose $billions every year.

  7. Howard Edgar says:

    I know a few forward-thinking, tech-savvy “concierge-style” docs who do Skype or FaceTime visits with their patients now. Not robots. Real physicians. Face-to-face in cyberspace. Teledoc sounds worth watching.

  8. heretic001 says:

    I believe the VA does tele-med

  9. medicrn81 says:

    Right now a lot of these services are geared towards convenient care/urgent care. I am looking forward to the time when a lot more primary care providers are a common thing through telemedicine. At that point I may transition myself into a primary care provider (currently work in ER.)

  10. glomerulus says:

    Being an optometrist, I know a lot of people will never give up the face-to-face encounter. In the eye care sphere, online refraction technology is coming. And there are a lot of stupid optometrists who think it will never be allowed to happen, but it will (because corporations will hire an MD to sign off on all the eyeglass prescriptions), the optometry boards have no power over this, really. Then thousands of optometrists will be out of work.

    I have positioned my practice to concentrate on eye diseases, not eyeglasses, which is a helluva hedge against the coming paradigm shift. I will have retired by the time it all happens, but I might go back into the business when I can hire optometrists at $250/day (whereas I now have to offer $600). So, maybe I should invest in stock like this, because telemedicine could potentially build by business, not make it irrelevant.

  11. libikz40 says:

    I go to see my GP Doctor every three months. He does not guess about my health. His LAB takes my blood, I pee in the cup and the lab gives me other tests, as needed then the LAB sends the results to the doctor. The doctor then calls me and I go to his office to discuss his findings. NO GESS WORK, JUST ROUTINE TESTS. THIS SHOULD WORK WITH TELEDOC.

  12. Tom says:

    Teladoc has been a winner ever since I nvested in it earlier this year

  13. Mike says:

    I think there is huge potential here and am going to start looking into it. To start, I hate doctors. I hate going to one. I hate talking to one. Been that way all my life and that is never going to change. I hate driving to a doctors office. I hate walking into a doctors office. I hate talking to the receptionist. I hate sitting in the waiting room. And I bet there are a lot of people like me.

  14. d says:

    Hi Travis, My first comment . Always enjoy your analysis and thanks.
    On another topic, what are the China stocks to follow before they come under MSCI May 31st and Aug 3st – as touted by the Stansberry Digest or similar??.

  15. gaicecoach says:

    Anyone know of similar companies in this field? Who is Teledoc competition?

  16. mwojnaro says:

    Anyone remeber dial up internet? This may be the beginning of receiving the annual physical or a suppliment to urgent care. Hospitals, locally, are opening up urgent care facilities. CVS has its version of on demand health care. One concept to watch for sure.

  17. sajenmathews says:

    Access to telehealth services for seniors is poised to take off in coming years thanks to the newly approved federal budget that enables virtual doctor visits for Americans covered by Medicare Advantage plans.

    https://www.forbes.com/sites/brucejapsen/2018/02/10/congress-boosts-medicare-coverage-for-virtual-doctor-visits/#5f150dad3be4

  18. Dave S. says:

    It’s about a year later and let’s see how the stock has done: $51.60/share, which is a gain of about 6%. Not exactly Netflixian, but better than a loss.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.